FXI/FXIa inhibition may allow for inhibition of contact pathway activation of thrombin generation depicted on the right side of the coagulation cascade, while allowing for tissue factor mediated activation of thrombin as seen on the left side, thus preventing thrombosis mediated by pathologic activation of thrombin by devices and inflammatory activators of coagulation while preserving hemostasis in the setting of trauma.